Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-arm Open-label Study Assessing Short-term (Week 6, 16) and Long-term (Week 32) Efficacy of Guselkumab in Adult Participants With Pyoderma Gangrenosum

NCT06563323 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT06563323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06563323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-arm Open-label Study Assessing Short-term (Week 6, 16) and Long-term (Week 32) Efficacy of Guselkumab in Adult Participants With Pyoderma Gangrenosum
Lead sponsor
Oregon Health and Science University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
February 1, 2025
Completion date
October 5, 2027
Enrollment
17 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pyoderma, pyoderma gangrenosum, skin diseases, skin ulcer, wound heal